Viela Bio Inc (NASDAQ:VIE)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - VIE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - VIE

  • Market Cap$1.979bn
  • SymbolNASDAQ:VIE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS9266131005

Company Profile

Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.

Latest VIE news

Currently there for this company. Visit our news hub for other news .